Report Store Get Proposal

Home Blog Tag Juvenile psoriatic arthritis

Juvenile Psoriatic Arthritis

recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo

Aug 24, 2021

AstraZeneca’s Ultomiris; HebaBiz’s Siroquine; Pfizer’s XELJANZ; Bristol Myers Squibb’s Opdivo; and Masimo’s PVi

AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy in Patients with Amyotrophic Lateral Sclerosis AstraZeneca's 39 billion USD complete acquisition of Alexion took over just a few months back. Unpleasant news strike hard for their first deal in the rare neu...

Read More...

Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies

Snippets - A Small piece of News or Article

Jul 04, 2025

A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray

Articles

Jun 10, 2025

ADCs in Lung Cancer Treatment: ENHERTU’s Rise, HER3 & TROP-2 Challenges, and What’s Next in the Pipeline

Articles

May 09, 2025

LEQEMBI: A New Hope for Alzheimer’s Disease Patients

Articles

Feb 12, 2025

Toll-like Receptors Agonist

TLR 7 and 8 Agonist

Gene Therapies Whitepaper

Toll-like Receptors Agonist

TLR 7 and 8 Agonist

Gene Therapies Whitepaper

Newsletter/Whitepaper